Showing 2 posts of 2 posts found.
Gilead has revealed it is to acquire the immunology firm Forty Seven in a deal valued at $95.50 per share …
Forty Seven, a spinout from Stanford University, has had a busy few days – first announcing that it had filed …
Santen joins inaugural Global Summit for Eye Health as partner
EHP Awards 2027 open for entries following outstanding inaugural year
NHS spends £240m storing patient records as digital reforms gather pace
NHS awards national diabetes education contract to Leicester programme
InnoScot highlights NHS Scotland’s progress towards net zero healthcare